PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres-the protective ...

Within the tumor microenvironment, networks of cells and molecular signals form a dynamic landscape that drives disease ...

The Cancer Society New Zealand is proud to announce over $1 million in funding for five ground-breaking research projects aimed at improving cancer prevention, detection and treatment for all New ...

Tumour growth is reduced by exercise due to a shift in the body’s metabolism that means muscle cells outcompete cancer cells ...

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres—the protective ...

The FDA has approved pegfilgrastim-unne (Armlupeg) for the treatment of patients with nonmyeloid cancers undergoing treatment ...

Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic ...

New research reveals that cells can sense far beyond their immediate surroundings, a biological ability once thought to ...

What causes people with cancer to die?The answer, it turns out, may be much different than the medical community has long ...

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.